In This Article
What an Editorial System Is — and Is Not
An editorial system is the combination of processes, governance structures, tools, and standards that enable an organization to produce content reliably, accurately, and at scale. It is distinct from a content strategy (which defines what content to produce and why) and a content calendar (which plans what will be produced when). An editorial system defines how production actually happens.
In life sciences and digital health contexts, editorial systems must address two requirements that general content frameworks often ignore: accuracy verification (content must be factually correct and scientifically sound) and compliance review (content must meet regulatory, legal, and MLR requirements before publication). These requirements add complexity that must be designed into the editorial system from the outset.
The Five Layers of an Editorial System
Layer 1: Content Governance
Governance defines who has authority over content decisions, how disputes are resolved, and how the editorial system itself is maintained. In life sciences, governance typically involves representation from medical, legal, regulatory, commercial, and marketing functions. Clear governance prevents the most common editorial bottleneck: reviews that stall because ownership and authority are ambiguous.
Layer 2: Content Architecture
Content architecture defines the taxonomy of content types your organization produces, the structural template for each type, and the review and approval requirements that apply to each. A well-designed content architecture eliminates thousands of micro-decisions from the production process by answering common questions once, systematically.
A pharmaceutical commercial organization might define five to ten content types — detail aids, patient education brochures, HCP email sequences, medical congress presentations, digital banner ads — each with its own structure template, required review checklist, and approval workflow.
Layer 3: Production Workflow
The production workflow defines the step-by-step process from content brief to published asset, including the roles responsible at each step, the criteria for advancing to the next step, and the escalation paths for items that fail criteria.
Brief
Objectives, audience, key messages
Draft
Writer produces first draft to template
Editorial Review
Accuracy, structure, tone
MLR Review
Medical / Legal / Regulatory
Final Approval
Designated authority sign-off
Publish
Distribution & tracking
Layer 4: Review and Approval Infrastructure
In life sciences, the review and approval layer is where most editorial system failures occur. Organizations that have not intentionally designed this layer typically develop informal, inconsistent patterns: reviews requested by email, feedback delivered in unstructured comments, approval records scattered across individuals’ sent folders.
A well-designed review infrastructure includes: a designated workflow tool that routes content to reviewers and tracks status, standardized review checklists for each content type and reviewer role, a clear protocol for managing conflicting feedback, a formal approval record documenting who approved what and when, and version control ensuring reviewers always work on the current draft.
Layer 5: Content Maintenance and Retirement
Published content does not stay accurate indefinitely. Clinical data updates, regulatory guidance changes, label revisions, and market access shifts can all render previously approved content outdated or non-compliant. An editorial system must include a mechanism for tracking published content, triggering reviews when relevant changes occur, and retiring content that has passed its useful life or accuracy threshold.
AI’s Role in Modern Editorial Systems
| Editorial Stage | AI Application | Human Role Preserved |
|---|---|---|
| Brief Development | Drafting brief templates from strategy documents; summarizing reference materials | Strategic direction, audience insight, business context |
| First Draft Production | Generating structured first drafts from approved briefs and reference materials | Voice, nuance, scientific accuracy judgment, brand alignment |
| Editorial Review | Automated checking against style guide, structure template, required elements | Substantive accuracy, tone, clarity, strategic alignment |
| Reference Verification | Automated checking that claims are supported by cited references | Interpretation of ambiguous or context-dependent claims |
| Maintenance Monitoring | Automated alerts when referenced guidelines or data are updated | Assessment of whether update affects content accuracy |
Implementation Approach
Phase 1 — Diagnosis and Design (4–6 weeks): Audit current content production processes, identify pain points and bottlenecks, define content types and governance structure, draft production workflow and review infrastructure designs. Involve key stakeholders from all review functions in co-designing the system.
Phase 2 — Piloting and Refinement (6–8 weeks): Pilot the new system with a defined subset of content. Measure cycle time, review iteration rates, and stakeholder satisfaction. Collect structured feedback and refine the system before full deployment.
Phase 3 — Full Deployment and Optimization (Ongoing): Roll out the system organization-wide. Train all participants. Monitor performance metrics. Review and refine quarterly as volume, content types, and regulatory requirements evolve.
Conclusion
An effective editorial system is one of the highest-leverage investments a life sciences or digital health organization can make in its content capability. It reduces cost per asset, accelerates time-to-market, improves quality and consistency, and manages compliance risk systematically.
The investment is primarily in design, process, and change management — not technology. Organizations that approach editorial system development with the same rigor they apply to other operational systems consistently outperform those that try to solve content production challenges with tools alone.
References & Sources
- 2025 Global Health Care Executive Outlook — Deloitte.
- Life Sciences and Health Care Industry Insights Report 2026 — Deloitte, November 2025.
- State of Gen AI in the Enterprise — Fourth Wave — Deloitte AI Institute, January 2025.
- Draft Guidance: AI to Support Regulatory Decision-Making — U.S. FDA, January 2025.
- EU AI Act — European Commission, August 2024.
#SakaraDigital #ContentOperations #LifeSciences #EditorialSystems #RegulatoryContent








Your perspective matters—join the conversation.